Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0005886 | plasma membrane | 3 | 1 |
Related structures:
AlphaFold database: E9B3I7
Term | Name | Level | Count |
---|---|---|---|
GO:0000041 | transition metal ion transport | 7 | 1 |
GO:0006810 | transport | 3 | 1 |
GO:0006811 | monoatomic ion transport | 4 | 1 |
GO:0006812 | monoatomic cation transport | 5 | 1 |
GO:0006829 | zinc ion transport | 8 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0030001 | metal ion transport | 6 | 1 |
GO:0034220 | monoatomic ion transmembrane transport | 3 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
GO:0055085 | transmembrane transport | 2 | 1 |
GO:0071577 | zinc ion transmembrane transport | 6 | 1 |
GO:0098655 | monoatomic cation transmembrane transport | 4 | 1 |
GO:0098660 | inorganic ion transmembrane transport | 4 | 1 |
GO:0098662 | inorganic cation transmembrane transport | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005215 | transporter activity | 1 | 2 |
GO:0005385 | zinc ion transmembrane transporter activity | 7 | 1 |
GO:0008324 | monoatomic cation transmembrane transporter activity | 4 | 2 |
GO:0015075 | monoatomic ion transmembrane transporter activity | 3 | 2 |
GO:0015318 | inorganic molecular entity transmembrane transporter activity | 3 | 2 |
GO:0022857 | transmembrane transporter activity | 2 | 2 |
GO:0022890 | inorganic cation transmembrane transporter activity | 4 | 2 |
GO:0046873 | metal ion transmembrane transporter activity | 5 | 2 |
GO:0046915 | transition metal ion transmembrane transporter activity | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 216 | 218 | PF00675 | 0.242 |
CLV_NRD_NRD_1 | 32 | 34 | PF00675 | 0.527 |
CLV_PCSK_FUR_1 | 30 | 34 | PF00082 | 0.435 |
CLV_PCSK_KEX2_1 | 216 | 218 | PF00082 | 0.246 |
CLV_PCSK_KEX2_1 | 32 | 34 | PF00082 | 0.532 |
CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.394 |
CLV_PCSK_SKI1_1 | 245 | 249 | PF00082 | 0.473 |
DEG_SCF_TRCP1_1 | 123 | 129 | PF00400 | 0.534 |
DEG_SPOP_SBC_1 | 266 | 270 | PF00917 | 0.374 |
DOC_CKS1_1 | 228 | 233 | PF01111 | 0.413 |
DOC_CYCLIN_yCln2_LP_2 | 228 | 234 | PF00134 | 0.362 |
DOC_MAPK_MEF2A_6 | 171 | 180 | PF00069 | 0.497 |
DOC_PP2B_LxvP_1 | 24 | 27 | PF13499 | 0.553 |
DOC_USP7_MATH_1 | 121 | 125 | PF00917 | 0.708 |
DOC_USP7_MATH_1 | 207 | 211 | PF00917 | 0.601 |
DOC_USP7_MATH_1 | 250 | 254 | PF00917 | 0.454 |
DOC_USP7_MATH_1 | 262 | 266 | PF00917 | 0.480 |
DOC_USP7_MATH_1 | 284 | 288 | PF00917 | 0.255 |
DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.374 |
DOC_WW_Pin1_4 | 227 | 232 | PF00397 | 0.360 |
DOC_WW_Pin1_4 | 245 | 250 | PF00397 | 0.411 |
DOC_WW_Pin1_4 | 75 | 80 | PF00397 | 0.401 |
LIG_14-3-3_CanoR_1 | 20 | 27 | PF00244 | 0.750 |
LIG_14-3-3_CanoR_1 | 32 | 40 | PF00244 | 0.643 |
LIG_Actin_WH2_2 | 230 | 247 | PF00022 | 0.174 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.616 |
LIG_BRCT_BRCA1_1 | 210 | 214 | PF00533 | 0.603 |
LIG_BRCT_BRCA1_1 | 252 | 256 | PF00533 | 0.422 |
LIG_BRCT_BRCA1_1 | 286 | 290 | PF00533 | 0.300 |
LIG_Clathr_ClatBox_1 | 150 | 154 | PF01394 | 0.519 |
LIG_CSL_BTD_1 | 6 | 9 | PF09270 | 0.606 |
LIG_FHA_1 | 111 | 117 | PF00498 | 0.664 |
LIG_FHA_1 | 130 | 136 | PF00498 | 0.593 |
LIG_FHA_1 | 144 | 150 | PF00498 | 0.528 |
LIG_FHA_1 | 162 | 168 | PF00498 | 0.451 |
LIG_FHA_1 | 20 | 26 | PF00498 | 0.736 |
LIG_FHA_1 | 246 | 252 | PF00498 | 0.504 |
LIG_FHA_1 | 271 | 277 | PF00498 | 0.391 |
LIG_FHA_1 | 308 | 314 | PF00498 | 0.174 |
LIG_FHA_1 | 317 | 323 | PF00498 | 0.317 |
LIG_FHA_1 | 40 | 46 | PF00498 | 0.437 |
LIG_FHA_1 | 58 | 64 | PF00498 | 0.326 |
LIG_LIR_Gen_1 | 185 | 195 | PF02991 | 0.513 |
LIG_LIR_Gen_1 | 287 | 298 | PF02991 | 0.397 |
LIG_LIR_Gen_1 | 43 | 53 | PF02991 | 0.538 |
LIG_LIR_Gen_1 | 86 | 95 | PF02991 | 0.249 |
LIG_LIR_Nem_3 | 185 | 190 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 287 | 293 | PF02991 | 0.326 |
LIG_LIR_Nem_3 | 43 | 49 | PF02991 | 0.555 |
LIG_LIR_Nem_3 | 86 | 90 | PF02991 | 0.399 |
LIG_Pex14_1 | 7 | 11 | PF04695 | 0.651 |
LIG_Rb_LxCxE_1 | 296 | 310 | PF01857 | 0.237 |
LIG_SH2_NCK_1 | 187 | 191 | PF00017 | 0.466 |
LIG_SH2_PTP2 | 292 | 295 | PF00017 | 0.362 |
LIG_SH2_STAT5 | 292 | 295 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 324 | 327 | PF00017 | 0.414 |
LIG_SH3_3 | 258 | 264 | PF00018 | 0.390 |
LIG_SH3_3 | 3 | 9 | PF00018 | 0.591 |
LIG_SH3_3 | 89 | 95 | PF00018 | 0.348 |
LIG_SUMO_SIM_anti_2 | 131 | 139 | PF11976 | 0.563 |
LIG_SUMO_SIM_anti_2 | 230 | 236 | PF11976 | 0.174 |
LIG_SUMO_SIM_anti_2 | 268 | 280 | PF11976 | 0.387 |
LIG_SUMO_SIM_anti_2 | 60 | 65 | PF11976 | 0.312 |
MOD_CK1_1 | 128 | 134 | PF00069 | 0.650 |
MOD_CK1_1 | 265 | 271 | PF00069 | 0.508 |
MOD_CK1_1 | 274 | 280 | PF00069 | 0.368 |
MOD_CK1_1 | 75 | 81 | PF00069 | 0.460 |
MOD_CK2_1 | 185 | 191 | PF00069 | 0.587 |
MOD_Cter_Amidation | 30 | 33 | PF01082 | 0.498 |
MOD_GlcNHglycan | 123 | 126 | PF01048 | 0.488 |
MOD_GlcNHglycan | 161 | 164 | PF01048 | 0.369 |
MOD_GlcNHglycan | 167 | 170 | PF01048 | 0.358 |
MOD_GlcNHglycan | 195 | 198 | PF01048 | 0.341 |
MOD_GlcNHglycan | 252 | 255 | PF01048 | 0.686 |
MOD_GlcNHglycan | 286 | 289 | PF01048 | 0.328 |
MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.331 |
MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.662 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.699 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.764 |
MOD_GSK3_1 | 161 | 168 | PF00069 | 0.624 |
MOD_GSK3_1 | 245 | 252 | PF00069 | 0.441 |
MOD_GSK3_1 | 262 | 269 | PF00069 | 0.457 |
MOD_GSK3_1 | 270 | 277 | PF00069 | 0.419 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.592 |
MOD_N-GLC_1 | 207 | 212 | PF02516 | 0.425 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.521 |
MOD_NEK2_1 | 322 | 327 | PF00069 | 0.462 |
MOD_NEK2_1 | 40 | 45 | PF00069 | 0.557 |
MOD_NEK2_1 | 57 | 62 | PF00069 | 0.225 |
MOD_NEK2_1 | 98 | 103 | PF00069 | 0.576 |
MOD_PKA_2 | 19 | 25 | PF00069 | 0.697 |
MOD_PKA_2 | 208 | 214 | PF00069 | 0.623 |
MOD_Plk_1 | 98 | 104 | PF00069 | 0.577 |
MOD_Plk_2-3 | 185 | 191 | PF00069 | 0.622 |
MOD_Plk_4 | 274 | 280 | PF00069 | 0.406 |
MOD_Plk_4 | 286 | 292 | PF00069 | 0.303 |
MOD_Plk_4 | 293 | 299 | PF00069 | 0.217 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.341 |
MOD_ProDKin_1 | 227 | 233 | PF00069 | 0.360 |
MOD_ProDKin_1 | 245 | 251 | PF00069 | 0.415 |
MOD_ProDKin_1 | 75 | 81 | PF00069 | 0.396 |
TRG_DiLeu_BaLyEn_6 | 214 | 219 | PF01217 | 0.557 |
TRG_ENDOCYTIC_2 | 187 | 190 | PF00928 | 0.507 |
TRG_ENDOCYTIC_2 | 292 | 295 | PF00928 | 0.362 |
TRG_ER_diArg_1 | 215 | 217 | PF00400 | 0.489 |
TRG_ER_diArg_1 | 30 | 33 | PF00400 | 0.653 |
TRG_Pf-PMV_PEXEL_1 | 216 | 220 | PF00026 | 0.424 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5U6 | Leptomonas seymouri | 48% | 95% |
A0A1X0P3V2 | Trypanosomatidae | 29% | 75% |
A0A3R7MSD3 | Trypanosoma rangeli | 31% | 100% |
A0A3S7X6D4 | Leishmania donovani | 88% | 100% |
A4HL46 | Leishmania braziliensis | 69% | 100% |
A4I8M5 | Leishmania infantum | 88% | 100% |
C9ZPV0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 90% |
Q4Q4L3 | Leishmania major | 85% | 100% |
V5BAE0 | Trypanosoma cruzi | 37% | 92% |